RxDoctor Payments Data

Herman Hedriana, MD

Maternal & Fetal Medicine · Sacramento, CANPI 1235174822

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Janssen Research & Development, LLC at 54.4% of the total. Reporting peaked in 2020 at $2,187 and has fallen 50.5% since, to $1,082 in 2025. Among maternal & fetal medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,042in general payments, 2019–2025

Across 31 payments — averaging $162.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$3K
  • Sage Therapeutics, LLC$2K
  • GE HealthCare$384
  • AMAG Pharmaceuticals, Inc.$86
  • Hologic Sales And Service, LLC$17
  • Organon$14
$97,440in research payments, 2019–2025

Across 5 payments — averaging $19,488 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$50K
  • Pfizer$48K

What the payments were for

  • Consulting fees$1,80036%
  • Travel & lodging$2,09041%
  • Food & beverage$1,10322%
  • Education$491%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,042 in reported general payments places this provider in the 90th percentile of 178 maternal & fetal medicine providers in California.

See all maternal & fetal medicine providers in California

Medicare billing

Part B allowed, 2024
$1,729
Medicare patients
11
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other maternal & fetal medicine in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →